Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale. uri icon

authors

  • Badrising, Umesh A
  • Brusch, Anna
  • Chan, Doris
  • Coudert, Jerome D
  • Fairchild, Timothy
  • Jain, Gayatri
  • Kiernan, Matthew C
  • Leonard, Dag
  • Lloyd, Thomas
  • Schmidt, Jens
  • McDermott, Mike P
  • Henderson, Robert
  • Sanders, Lauren
  • Lowe, Christine
  • van der Kooi, Anneke J
  • Weihl, Chris
  • Mohassel, Payam
  • Simpson, Marion
  • Carroll, Antonia
  • Cooper, Ian
  • Beer, Kelly
  • Hiscock, Krystyne
  • Reddel, Stephen
  • Walters, Susan
  • Panicker, Annik
  • Doverty, Althea
  • Heim, Andrew
  • van Heur-Neuman, Marjolein
  • Benveniste, Olivier
  • Dimachkie, Mazen M
  • Needham, Merrilee
  • Corbett, Alastair
  • Liang, Christina
  • Reardon, Katrina
  • Ghaoui, Roula
  • Bulsara, Max
  • Brady, Stefen

publication date

  • February 26, 2025